Indication | Project code | Discovery | Non-Clinical | Phase I | Phase II | |||||
---|---|---|---|---|---|---|---|---|---|---|
Lead | CDR optimization & Candidate |
Cell line & Process development |
||||||||
Cancer | APB-A001 |
Project code | Target combinatory Therapy |
Discovery | Non-Clinical | Phase I | Phase II |
---|---|---|---|---|---|
APB-A001 | Chemotherapy | ||||
Immunotherapy | |||||
Radiotherapy |
Indication | Project code | Discovery | Non-Clinical (GLP-Toxicity) |
Phase I | Phase II | ||
---|---|---|---|---|---|---|---|
Lead | Candidate | Cell line & Process development |
|||||
Cancer | APB-B001 | ||||||
APB-B002 |